Zotefoams plc (LSE:ZTF), the Croydon-based maker of high-performance foams found in everything from running shoes to aircraft interiors, has just delivered a first half that looks strong on almost every line: Revenue up 23%, adjusted operating profit up 34% and the Interim Dividend raised. Yet the same 5 August 2026 statement warned that volumes from its largest footwear customer will fall through the rest of 2026 and into 2027, and confirmed a UK restructuring that puts more than 100 jobs under consultation.

The key question for investors on the London Stock Exchange is therefore one of timing. Can Diversification into transport, construction and industrial markets, plus a newly acquired Spanish business, carry Earnings while high-volume footwear production shifts from Croydon to a new plant in Vietnam?

Interim results: record half, but footwear enters a transition year

On 5 August 2026 Zotefoams reported results for the six months to 30 June 2026. Revenue rose 23% to £95.2m from £77.4m, helped by a £14.8m first full-half contribution from Overseas Konstellation Company (OKC), the Spanish technical-foam converter acquired in November 2025. Organic growth was 4%, or 6% at constant currency.

Gross Margin improved 100 basis points to 35.6% and adjusted operating profit climbed 34% to £16.3m, lifting the adjusted Operating Margin to 17.1% from 15.8%. Adjusted profit before tax was £15.3m, up 34%, while statutory profit before tax rose 23% to £14.0m after £1.3m of adjusting items. Adjusted Basic Earnings Per Share increased 29% to 25.70p and the interim dividend was raised 5.2% to 2.63p.

Group chief executive Ronan Cox said that “strong growth across target non-footwear markets, doubling of Asia revenue and OKC’s first full-half contribution drove strong revenue, profit and margin growth, even as footwear normalised following exceptional 2025 demand.”

That normalisation was significant. Revenue from the group’s largest customer, a footwear Brand historically identified in Zotefoams’ reports as Nike, fell 23% to £28.5m from £37.0m. Management expects footwear volumes to be lower through the second half and into 2027 as production migrates to Vietnam and shifts from foam sheet to three-dimensional preforms, with recovery anticipated from 2028.

Alongside the results, the group announced a repositioning of its Croydon site towards innovation and non-footwear applications. A consultation affecting more than 100 employees has begun, with expected annualised savings of around £4m, payback of under a year and one-off costs to be booked in the second half of 2026.

What Zotefoams does

Zotefoams (LSE:ZTF) describes itself as the world’s largest manufacturer of lightweight crosslinked polyolefin block foams, sold under the AZOTE brand, and a global leader in supercritical foams. Its proprietary process uses nitrogen gas at high pressure rather than chemical blowing agents, producing pure, closed-cell materials prized for their strength-to-weight ratio.

The group reports through three regions. EMEA, anchored by Croydon and now including OKC’s Spanish sites, generated £73.6m of first-half revenue; North America contributed £18.7m and Asia £2.9m. By end market, Transport & Smart Technologies was the largest vertical at £46.1m in H1 2026, followed by Consumer & Lifestyle at £31.2m and Construction & Other Industrial at £17.9m.

Zotefoams sells foam sheet and, increasingly, converted components to manufacturers in aerospace, rail, automotive, medical, sports, building products and packaging. The OKC deal, at €27.6m upfront plus up to €8.4m deferred for a Business with 2024 revenue of €30.1m and EBITDA of €5.3m, moves the group up the value chain towards being a solutions provider.

Financial performance: a record 2025 and expanded funding

The 2025 preliminary results of 17 March 2026 set the platform. Revenue for the year to 31 December 2025 rose 7.2% to £158.5m, adjusted operating profit jumped 26% to £22.8m and adjusted profit before tax increased 39% to £21.2m, with adjusted basic EPS of 38.0p, up 46%. The total dividend was lifted 5% to 7.85p, Operating Cash Flow reached £39.7m with cash conversion of 101%, and return on Capital employed improved to 13.9% from 11.7%.

First-half 2026 cash dynamics were weaker, reflecting heavy investment. Operating cash flow fell to £8.2m from £15.8m, Capital Expenditure of £7.2m went mainly to Vietnam, and free cash flow was a negative £0.4m against £6.2m a year earlier. Covenant net Debt rose to £39.1m from £31.5m at the 2025 year end, though Leverage of 0.98 times sits well inside the 3.5 times covenant limit. A refinanced £90m revolving Credit facility, expanded from £50m in early 2026, left £50.2m of Liquidity headroom at 30 June.

Management maintained full-year guidance, citing market expectations of £190.8m revenue and £26.3m adjusted profit before tax for 2026. Medium-term targets call for revenue above £230m and operating profit above £40m by 2029.

What could drive the shares next

The most visible catalyst is Vietnam. The facility, a roughly $32m project in which partner Seoheung holds a 17.5% stake for $10m, is on track for trial production in October 2026. Evidence that preform output is ramping on schedule would de-risk the group’s largest revenue stream.

OKC is a second lever. The business was described as earnings accretive and ahead of its integration plan, with early cross-selling wins secured. Continued growth in Transport & Smart Technologies and in North America, where operating margin more than doubled to 17.6% in the first half, would support the case that the group is becoming less dependent on one customer.

Delivery of the £4m of annualised Croydon savings, the new South Korean footwear innovation centre and a year-end trading update are further items to watch.

Risks investors should watch

Customer concentration remains the defining risk for Zotefoams (LSE: ZTF). One footwear customer contributed £28.5m of £95.2m first-half revenue, and management expects those volumes to decline further through 2027. Slippage in the Vietnam ramp-up, or a change in that customer’s sourcing, would be felt quickly in group earnings.

Execution risk is elevated. Zotefoams is simultaneously commissioning a plant in Vietnam, restructuring UK operations, integrating OKC and establishing a Korean innovation centre, and management has flagged temporary margin pressure in the second half.

Balance sheet flexibility has narrowed. Net debt rose sharply in the first half, free cash flow turned negative and OKC deferred payments of £3.0m fall due in October 2026 and up to £1.3m in 2027, while Vietnam will absorb further capital before it generates returns. Foreign exchange is a recurring headwind, with constant-currency growth running ahead of reported figures.

Outlook

Zotefoams enters the second half of 2026 with a record profit base, its broadest portfolio yet and guidance intact. The 5 August statement made clear, however, that the next 18 months are a transition in which footwear revenue falls before it recovers and cash is consumed by Vietnam, restructuring and deferred Acquisition payments.

Investors should track three things: whether Vietnam meets its October trial-production milestone, whether OKC and the non-footwear verticals grow fast enough to offset the footwear dip, and whether net debt stabilises as capital expenditure peaks. The shares, quoted at around 420p on 7 August according to Sharecast, sit below their 52-week high of 469.5p.